UNSPSC 51332856: Levomepromazine maleate

This classification denotes a phenothiazine, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5KN5Y9V01K. European Medicines Agency schedules Levomepromazine maleate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02909MIG. Levomepromazine maleate generally arises in the molecular formula C19H24N2OS.C4H4O4. The term 'levomepromazine maleate' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule levomepromazine maleate under HS 29343090.

As of Q4 2014, LEVOMEPROMAZINE MALEATE remains US FDA's Preferred Term for this commodity. Levomepromazine maleate bears US NLM identifiers UMLS ID C0607673 and NCI Concept Code C66009. SMILES: C[C@@H](CN1C2CCCCC2SC3C1CC(CC3)OC)CN(C)C.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51332856 Levomepromazine maleate is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single opportunity in the dataset—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—procures emergency overdose-reversal medication and harm-reduction equipment, not levomepromazine maleate, a first-generation antipsychotic. The mismatch suggests either a cataloging error or a systematic tagging inconsistency in the state and local procurement data. Without additional opportunities that actually seek levomepromazine maleate or related pharmaceutical products under this code, the Commodity code shows no actionable recent activity.

The Seminole County procurement, posted June 30, 2026 with a July 26, 2023 response deadline (date discrepancy in source), sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract was structured as a two-year initial term with a one-year renewal option and included standard compliance requirements—E-Verify, drug-free workplace certification, workers' compensation and commercial general liability insurance—with potential FEMA funding. While this opportunity demonstrates state and local interest in pharmaceutical procurement and emergency health supplies, it remains an isolated data point under the levomepromazine code and does not establish a usable pattern for business development targeting this specific Commodity.